This content is machine translated Cystitis When going to the toilet becomes a pain! About 50-70% of all women have cystitis at least once a year. Repeated bladder infections occur in approximately 5-10% of cases. Phytotherapeutic preparations based on nasturtium and horseradish can provide…
View Post 1 min This content is machine translated Medicine Brief Subject Information Here you will find a list of current short subject information.
View Post 4 min This content is machine translated Orphan disease Excellent and innovative treatment for spinal muscular atrophy Spinal muscular atrophy is associated with rapid loss of motor neurons, resulting in, among other things, impaired breathing. It represents the most common genetic cause of infant and young child…
View Post 3 min This content is machine translated Migraine prophylaxis Current real-world data confirm long-term efficacy and safety Migraine patients have a hard time: pain, nausea and sensitivity to light significantly limit their quality of life. Everyday and social life suffers – more than 8 days a month…
View Post 1 min This content is machine translated Precision Oncology First drug with tumor-independent indication approved New paths are being taken in cancer therapy. Precision oncology opens up the possibility of tailoring treatment no longer to the localization of the tumor, but to its cross-tissue molecular…
View Post 1 min This content is machine translated Cutaneous squamous cell carcinoma First systemic therapy approved Patients with metastatic or locally advanced cutaneous squamous cell carcinoma who are not candidates for curative surgery or curative radiation can now be treated with immunotherapy for the first time.…
View Post 3 min This content is machine translated Diabetic kidney disease Canagliflozin approved in fast track for diabetic nephropathy Kidney protection is extremely important for diabetes sufferers. Recently, canagliflozin became the first SGLT-2 inhibitor in Switzerland to receive a marketing authorization extension to reduce the risk of progression to…
View Post 3 min This content is machine translated Heart failure in type 2 diabetes Indication expansion for SGLT2 inhibitor and combination preparation Because of the high prevalence and mortality, it is particularly important to protect patients with type 2 diabetes from heart failure as early as possible. The indication expansion of dapagliflozin…
View Post 3 min This content is machine translated Chronic renal failure Dapagliflozin meets primary endpoints ahead of schedule The Phase III DAPA-CKD study will be terminated earlier than planned due to proven efficacy in patients with chronic renal failure. Dapagliflozin is the first SGLT2 inhibitor to show meaningful…
View Post 3 min This content is machine translated Chronic inflammatory bowel disease Ustekinumab approved in Switzerland for ulcerative colitis Swissmedic approves the use of the monoclonal antibody for the treatment of moderate to severe active ulcerative colitis where treatment goals are not achieved with conventional therapy.
View Post 2 min This content is machine translated SARS-CoV-2 Telemonitoring of respiratory therapy reduces risk of infection Innovative and digital devices for sleep and ventilation therapy enable efficient and clinically qualitative care for people with sleep-related breathing disorders, COPD and other chronic diseases. Telemonitoring offers an alternative…
